$40.78
0.37% today
Nasdaq, Feb 28, 04:50 pm CET
ISIN
GB00BYMT0J19
Symbol
LIVN

Livanova PLC Stock price

$40.93
-8.60 17.36% 1M
-5.67 12.17% 6M
-5.38 11.62% YTD
-14.97 26.78% 1Y
-37.89 48.07% 3Y
-27.95 40.58% 5Y
-27.57 40.25% 10Y
Nasdaq, Closing price Thu, Feb 27 2025
-0.52 1.25%
ISIN
GB00BYMT0J19
Symbol
LIVN
Sector

Key metrics

Market capitalization $2.22b
Enterprise Value $2.17b
P/E (TTM) P/E ratio 35.71
EV/FCF (TTM) EV/FCF 15.93
EV/Sales (TTM) EV/Sales 1.74
P/S ratio (TTM) P/S ratio 1.78
P/B ratio (TTM) P/B ratio 1.70
Revenue growth (TTM) Revenue growth 8.33%
Revenue (TTM) Revenue $1.25b
EBIT (operating result TTM) EBIT $163.17m
Free Cash Flow (TTM) Free Cash Flow $136.10m
Cash position $723.60m
EPS (TTM) EPS $1.15
P/E forward 16.82
P/S forward 1.70
EV/Sales forward 1.66
Short interest 4.72%
Show more

Is Livanova PLC a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,809 stocks worldwide.

Livanova PLC Stock Analysis

Unlock Scores for Free

Analyst Opinions

10 Analysts have issued a Livanova PLC forecast:

7x Buy
70%
3x Hold
30%

Analyst Opinions

10 Analysts have issued a Livanova PLC forecast:

Buy
70%
Hold
30%

Financial data from Livanova PLC

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
1,250 1,250
8% 8%
100%
- Direct Costs 380 380
3% 3%
30%
869 869
11% 11%
70%
- Selling and Administrative Expenses 482 482
4% 4%
39%
- Research and Development Expense 181 181
10% 10%
14%
206 206
30% 30%
16%
- Depreciation and Amortization 43 43
30% 30%
3%
EBIT (Operating Income) EBIT 163 163
67% 67%
13%
Net Profit 63 63
262% 262%
5%

In millions USD.

Don't miss a Thing! We will send you all news about Livanova PLC directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Livanova PLC Stock News

Neutral
Seeking Alpha
3 days ago
LivaNova PLC (LIVN) Q4 2024 Earnings Call Transcript
Neutral
Business Wire
3 days ago
LONDON--(BUSINESS WIRE)-- #cardiacsurgery--LivaNova PLC today reported fourth-quarter and full-year 2024 results and issued full-year 2025 guidance.
Neutral
Business Wire
7 days ago
LONDON--(BUSINESS WIRE)--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced Vladimir Makatsaria, Chief Executive Officer, will present in a fireside chat at the Barclays Global Healthcare Conference in Miami, Florida. The presentation will take place at 2:00 p.m. Eastern Time on Tuesday, March 11. The discussion will be available to all interested parties ...
More Livanova PLC News

Company Profile

LivaNova Plc is a global medical technology company, which engages in the development and delivery of important therapeutic solutions for the benefit of patients, healthcare professionals and healthcare systems. It operates through the following segments: Cardiovascular and Neuromodulation. The Cardiovascular segment develops, produces, and sells cardiopulmonary products, heart valves, and advanced circulatory support products. The Neuromodulation segment designs and markets NM-based medical devices for the treatment of epilepsy, depression, and obstructive sleep apnea. The company was founded on February 20, 2015 and is headquartered in London, the United Kingdom.

Head office United Kingdom
CEO Vladimir Makatsaria
Founded 1987
Website www.livanova.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today